Literature DB >> 11477613

Antenatal presentation of carnitine palmitoyltransferase II deficiency.

O N Elpeleg1, C Hammerman, A Saada, A Shaag, E Golzand, D Hochner-Celnikier, I Berger, M Nadjari.   

Abstract

Carnitine palmitoyl transferase (CPT) II deficiency is usually manifested around puberty by exercise induced myoglobinuria. Two Ashkenazi Jewish sibs with the rare antenatal form of CPTII deficiency are reported. On the 5th gestational month periventricular calcifications and markedly enlarged kidneys were found in both of them. The activity of CPTII in lymphocytes was undetectable and both sibs were homozygous for the 1237delAG mutation. Because of the serious consequences of homozygosity for this mutation, genotype determination of all Ashkenazi patients with the adolescent form of CPTII deficiency is warranted. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477613     DOI: 10.1002/ajmg.1457

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

1.  Disorders of fatty acid oxidation and autosomal recessive polycystic kidney disease-different clinical entities and comparable perinatal renal abnormalities.

Authors:  Agnes Hackl; Katrin Mehler; Ingo Gottschalk; Anne Vierzig; Marcus Eydam; Jan Hauke; Bodo B Beck; Max C Liebau; Regina Ensenauer; Lutz T Weber; Sandra Habbig
Journal:  Pediatr Nephrol       Date:  2017-01-12       Impact factor: 3.714

Review 2.  Antenatal manifestations of inborn errors of metabolism: prenatal imaging findings.

Authors:  Laurent Guibaud; Sophie Collardeau-Frachon; Audrey Lacalm; Mona Massoud; Massimiliano Rossi; Marie Pierre Cordier; Christine Vianey-Saban
Journal:  J Inherit Metab Dis       Date:  2016-11-16       Impact factor: 4.982

Review 3.  Newborn screening and renal disease: where we have been; where we are now; where we are going.

Authors:  J Lawrence Merritt; David Askenazi; Si Houn Hahn
Journal:  Pediatr Nephrol       Date:  2011-09-27       Impact factor: 3.714

4.  Neonatal carnitine palmitoyltransferase II deficiency: failure of treatment despite prolonged survival.

Authors:  Petra Hissink-Muller; Enrico Lopriore; Carolien Boelen; Frans Klumper; Marinus Duran; Frans Walther
Journal:  BMJ Case Rep       Date:  2009-06-26

Review 5.  Clinical 1H MRS in childhood neurometabolic diseases - part 2: MRS signatures.

Authors:  Matthew T Whitehead; Lillian M Lai; Stefan Blüml
Journal:  Neuroradiology       Date:  2022-02-28       Impact factor: 2.804

6.  Cerebral Lipid Accumulation Detected by MRS in a Child with Carnitine Palmitoyltransferase 2 Deficiency: A Case Report and Review of the Literature on Genetic Etiologies of Lipid Peaks on MRS.

Authors:  Carlos R Ferreira; Molly H Silber; Taeun Chang; Jonathan G Murnick; Brian Kirmse
Journal:  JIMD Rep       Date:  2015-11-05

7.  Cystic renal dysplasia as a leading sign of inherited metabolic disease.

Authors:  Felix Distelmaier; Markus Vogel; Ute Spiekerkötter; Klaus Gempel; Dirk Klee; Stefan Braunstein; Heinz-Peter Groneck; Ertan Mayatepek; Udo Wendel; Bernd Schwahn
Journal:  Pediatr Nephrol       Date:  2007-07-19       Impact factor: 3.714

8.  Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency.

Authors:  M Vavlukis; A Eftimov; P Zafirovska; E Caparovska; B Pocesta; S Kedev; A J Dimovski
Journal:  Case Rep Genet       Date:  2014-01-20

9.  A surviving 24-month-old patient with neonatal-onset carnitine palmitoyltransferase II deficiency.

Authors:  Naohiro Ikeda; Shinsuke Maruyama; Kanna Nakano; Ryo Imakiire; Yumiko Ninomiya; Shunji Seki; Kosuke Yanagimoto; Yasuyuki Kakihana; Keiichi Hara; Go Tajima; Yasuhiro Okamoto; Yoshifumi Kawano
Journal:  Mol Genet Metab Rep       Date:  2017-05-09

10.  CPT-II deficiency needs to be detected in army personnel.

Authors:  Josef Finsterer
Journal:  Mol Genet Metab Rep       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.